Not reimbursing islet transplantation creates discrimination against patients with type 1 diabetes

CellR4 2019; 7: e2774
DOI: 10.32113/cellr4_201910_2774

  Topic: Islet of Langerhans transplantation     Category:

Abstract

In this commentary reviewing the activity of the University of Geneva islet transplantation program, the author argues that health care coverage of the procedure will stop discrimination against a subset of patients with type 1 diabetes in need of beta-cell replacement but unfit to receive a whole pancreas transplant.

To cite this article

Not reimbursing islet transplantation creates discrimination against patients with type 1 diabetes

CellR4 2019; 7: e2774
DOI: 10.32113/cellr4_201910_2774

Publication History

Submission date: 01 Oct 2019

Revised on: 11 Oct 2019

Accepted on: 29 Oct 2019

Published online: 31 Oct 2019